Latest News and Press Releases
Want to stay updated on the latest news?
-
15. august 2025Meddelelse nr. 19 BioPortos delårsresultat for andet kvartal 2025 - Fortsat fremdrift med fuld eksekvering af strategiske mål og stærk NGAL-salgsvækst. København, Danmark, 15. august...
-
August 15, 2025Announcement no. 19 BioPorto Interim Result for the Second Quarter of 2025 - Continued progress with full execution of strategic objectives and strong NGAL sales growth. Copenhagen,...
-
29. juli 2025 Meddelelse BioPorto A/S afholder webcast for investorer om resultatet for første halvår 2025 København, Danmark, 29. juli 2025 (GLOBE NEWSWIRE) – BioPorto A/S ("BioPorto" eller...
-
July 29, 2025 News release BioPorto A/S to host an investor webcast on the results for the first half of 2025 COPENHAGEN, DENMARK, July 29, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or...
-
July 28, 2025News Release BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants. Laboratory...
-
July 28, 2025News Release BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants. Laboratory...
-
27. juni, 2025Meddelelse nr. 18 Påbegyndelse af kommercialisering af ProNephro AKITM (NGAL) til diagnostisk brug i USA KØBENHAVN, DANMARK og BOSTON, MA, USA, 27. juni 2025 – BioPorto A/S...
-
June 27, 2025Announcement no. 18 Initiation of commercialization of ProNephro AKITM (NGAL) for diagnostic use in the US COPENHAGEN, DENMARK and BOSTON, MA, USA, June 27, 2025 – BioPorto A/S...
-
12. juni 2025Meddelelse nr. 17 Tildeling af Warrants København, Danmark, den 12. juni 2025 (GLOBE NEWSWIRE) – Bestyrelsen...
-
12 June 2025 Announcement no. 17 Grant of Warrants Copenhagen, Denmark, June 12, 2025, (GLOBE NEWSWIRE) – The Board of...